The wider view
MOTS-c, CJC-1295, ipamorelin, sermorelin. If you’ve opened a few tabs, the names may already be blurring. We’ll give each one a bit of room and explain the differences that matter.
We’re interested in what these peptides do, and what people hope they’ll do. Those aren’t always the same thing. A useful comparison keeps both in view. We look at the substance, the people or animals studied, and the result. Then we check how far the claim travels beyond it. You don’t need a biology degree to spot that gap.
MOTS-c comes from mitochondria, the small parts of cells that help turn fuel into energy. Your body makes it already. That doesn’t tell us whether an injected product is safe or useful.
The exercise paper measured natural MOTS-c in people and gave MOTS-c to mice. The treated mice performed better. That’s interesting, but it doesn’t show that an injection can replace exercise for people.
Both stimulate growth hormone release, through different signals. Being paired in a name doesn’t turn them into one substance, or give the pair its own proof.
The small CJC-1295 studies in healthy adults found higher hormone levels. They didn’t test the combination with ipamorelin or show better sleep or recovery. The form matters too: CJC-1295 with DAC has an attachment that helps it last longer. Findings don’t automatically carry over to the form without it.
Sermorelin also prompts growth hormone release. A childhood growth study found faster growth in children with a diagnosed hormone shortage. It had no comparison group.
That history doesn’t answer whether today’s adult use improves energy, sleep or ageing. The former approved medicine and a current compounded preparation are different questions as well.
| Name | What interests researchers | What remains open |
|---|---|---|
| MOTS-c | Fuel use and exercise biology | Human treatment benefits |
| CJC-1295 with ipamorelin | Growth hormone signals | Benefits of the combination |
| Sermorelin | Growth hormone release and childhood treatment | Adult wellness claims |
Our comparison explains why there’s no overall winner here.
The U.S. regulatory records we discuss don’t establish Australian prescribing rules or local availability. The name Aus Peptide doesn’t change that.
Within the U.S., compounded medicines aren’t FDA-approved. A prescription and a product approval mean different things. Our questions page takes up children’s research, confusing names and what paperwork can tell you.
